Managing Sexual Dysfunction in Depression

Dr Vivienne Miller

writer

Dr Vivienne Miller

GP and Medical Editor

Dr Vivienne Miller

Based on an interview with Dr Jon-Paul Khoo, psychiatrist, co-owner and director at the Toowong Specialist Clinic, Brisbane held at the Annual Women and Children’s Health Update, Melbourne, March 2018

Modern antidepressant medication is efficacious and effective for sufferers of major depressive disorder.

However, residual symptoms, even in those who appear to be in remission, are common and can contribute to ongoing distress. Sexual dysfunction is one particularly relevant example. Up to a quarter of the general population report this, and the rate increases to about half of those who are depressed but not on treatment.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Eugenia Pedagogos

Prof Eugenia Pedagogos

Kidney Function Tests Explained

Dr David Lim & Prof Richard Harvey

Dr David Lim & Prof Richard Harvey

Fireside Discussion – Chronic Sinusitis & Nasal Polyps Management Update

A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Acne Scarring

Dr Mitchell Creinin MD

Dr Mitchell Creinin MD

Natural Estrogen, Contraception and Clot Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.